Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy

Name: Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
License: Public Domain

Canadian Cancer Trials Group

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

mantle cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 272348
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.